Wednesday, May 12, 2021
Home Health and Fitness Ocugen to co-develop Bharat Biotech's COVID-19 vaccine candidate for US

Ocugen to co-develop Bharat Biotech’s COVID-19 vaccine candidate for US

Covaxin showed it was safe and triggered immune responses in an ongoing early-stage trial and is currently part of a late-stage trial in India.

RELATED ARTICLES

Six Pack Home Workouts in Telugu || By Krish health and Fitness

For online training whatsapp to : 7286046418 🤝Support us by like and share.🙏 Instagram link : @krish_health_and_fitness. #sixpack #homeworkout #nogymworkouts ............................................................................................... My...

Scottish Ballet Health and Fitness Episode 1: Core De Ballet

Tone up with Scottish Ballet's Core De Ballet, a specialised introduction to core-based ballet exercises. Join Gyrotonics Instructor Kate Menzies and dancers Luciana Ravizzi...

Crispy Tofu Bowl With Snap Pea-Miso Salad

MyFitnessPal is the leading app for tracking—and conquering—your nutrition and fitness goals. Log meals from a database of 14 million foods, track...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

AI and COVID 19

AI has much promise and potential for medicine and healthcare and contributed to combatting the COVID-19 pandemic in ways ranging from early detection and...

Verified ✅ Revolution Beauty USA Discount Code | Take 50% Discount With SavingTrendy

For More Updated Revolution Beauty USA Coupons Visit: In this video We are showing you how to apply discount codes at Revolutionbeautyusa.com. We wish your...

2011 WOMEN'S WORLD CUP FINAL: Japan 2-2 USA (3-1 PSO)

Japan - USA, FIFA Women's World Cup Germany 2011: The Japanese would not be denied and they became the first Asian winners of the...

Bill Gates Chooses Hideout At California’s ‘Vintage Club’ Amid Divorce – Hollywood Life

Bill Gates has reportedly been staying at a gorgeous ultra-exclusive California golf club for several months in the midst of his divorce from...

Recent Comments